Core Laboratories (CLB) Cash from Investing Activities (2022 - 2026)

Core Laboratories' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$3.9 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 139.11% year-over-year to -$3.9 million; the TTM figure through Jun 2026 stood at -$8.7 million (down 76.37% YoY), while the FY2025 annual figure was -$2.2 million, up 65.11% from the prior year.
• Cash from Investing Activities for Q2 2026 stood at -$3.9 million, down from -$3.4 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $2.4 million in Q3 2025, with the low at -$3.9 million in Q2 2026.
• The 5-year median for Cash from Investing Activities is -$1.8 million (2023), against an average of -$1.5 million.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities surged 587.37% in 2025, then sank 539.25% in 2026.
• Core Laboratories' Cash from Investing Activities stood at $1.1 million in 2022, then plunged by 331.19% to -$2.4 million in 2023, then sank by 45.5% to -$3.6 million in 2024, then dropped by 5.42% to -$3.8 million in 2025, then decreased by 4.77% to -$3.9 million in 2026.
• Business Quant data shows CLB's Cash from Investing Activities at -$3.9 million in Q2 2026, -$3.4 million in Q1 2026, and -$3.8 million in Q4 2025.